Protagenic Therapeutics, Inc.\new PTIX
OTC PTIX
$0.72 -0.03 (-4.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Protagenic Therapeutics, Inc.\new (PTIX) Change in Accured Expenses (2014 - 2026)

Updated

Protagenic Therapeutics, Inc.\new (PTIX) posted Change in Accured Expenses of -$9,038 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $256,758 a year earlier.

Analysis

Protagenic Therapeutics, Inc.\new (PTIX) Change in Accured Expenses (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Protagenic Therapeutics, Inc.\new was -$248,375; for FY2026 (ended Mar 31, 2026), it was $17,421, down 91.5% from FY2025.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of -44.8% (FY2021 to FY2026).
  • In prior fiscal years, Protagenic Therapeutics, Inc.\new's Change in Accured Expenses was $206,039 in FY2025, $463,127 in FY2024, -$183,832 in FY2023 and -$91,596 in FY2022.
  • Quarterly Change in Accured Expenses has run from a low of -$155,028 in fiscal Q3 2026 to a high of $256,758 in fiscal Q1 2026 over five years.
  • According to Business Quant data, Change in Accured Expenses for the three prior fiscal quarters was $13,537 (Q4 2026), -$155,028 (Q3 2026) and -$97,846 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 2.41 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 1.20 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn 338.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Protagenic Therapeutics, Inc.\new 1.30 Mn 1.30 Mn - -9,038.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9,038.00
Mar 31, 2026 13,537.00
Dec 31, 2025 -155,028.00
Sep 30, 2025 -97,846.00
Jun 30, 2025 256,758.00
Mar 31, 2025 174,095.00
Dec 31, 2024 218,595.00
Sep 30, 2024 107,789.00
Jun 30, 2024 345,900.00
Mar 31, 2024 -209,157.00
Dec 31, 2023 -304,674.00
Sep 30, 2023 -109,567.00
Jun 30, 2023 123,197.00
Mar 31, 2023 107,212.00
Dec 31, 2022 145,557.00
Sep 30, 2022 93,511.00
Jun 30, 2022 -319,095.00
Mar 31, 2022 -11,569.00
Dec 31, 2021 102,052.00
Sep 30, 2021 143,791.00
API Access

Protagenic Therapeutics, Inc.\new Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PTIX&period=max&api_key=YOUR_API_KEY